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Abstract
Background: The reduced cost and improved efficiency of whole genome sequencing (WGS) is drastically
improving the development of cats as biomedical models. Persian cats are models for Leber’s congenital amaurosis
(LCA), the most severe and earliest onset form of visual impairment in humans. Cats with innocuous breed-defining
traits, such as a bobbed tail, can also be models for somite segmentation and vertebral column development.
Methods: The first WGS in cats was conducted on a trio segregating for LCA and the bobbed tail abnormality.
Variants were identified using FreeBayes and effects predicted using SnpEff. Variants within a known haplotype
block for cat LCA and specific candidate genes for both phenotypes were prioritized by the predicted variant effect
on the proteins and concordant segregation within the trio. The efficiency of WGS of a single trio of domestic cats
was evaluated.
Results: A stop gain was identified at position c.577C > T in cat AIPL1, a predicted p.Arg193*. A c.5A > G variant
causing a p.V2A was identified in HES7. The variants segregated concordantly in a Persian – Japanese bobtail
pedigree. Over 1700 cats from 40 different breeds and populations were genotyped for the AIPL1 variant, defining
an allelic frequency in only Persian –related breeds of 1.15 %. A sub-set of cats was genotyped for the HES7 variant,
supporting the variant as private to the Japanese bobtail breed. Approximately 18 million SNPs were identified for
application in cat research. The cat AIPL1 variant would have been considered a high priority variant for evaluation,
regardless of a priori knowledge from previous genetic studies.
Conclusions: This study represents the first effort of the 99 Lives Cat Genome Sequencing Initiative to identify
disease - causing variants in the domestic cat using WGS. The current cat reference assembly is efficient for gene
and variant identification. However, as the feline variant database improves, development of cats as biomedical
models for human disease will be more efficient, providing an alternative, large animal model for drug and gene
therapy trials. Undiagnosed human patients with early-onset blindness should be screened for this AIPL1 variant.
The HES7 variant should further calibrate the somite segmentation clock.
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of Split 7, LCA4, Progressive retinal atrophy
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Background
Whole genome sequencing (WGS) is becoming the
standard of health care in humans [1–9], and is com-
monly used to discover causal variants in children with
otherwise undiagnosed congenital defects [10–13]. The
50-h and now the 26-h genome efforts have demon-
strated how genome medicine can be applied to health
management for acute care patients with time-critical
morbidity and mortalities [10, 11]. The improved effi-
ciency and lower costs of WGS now apply to all animal
species, including pet cats. Over 80 million cats are
owned in the USA and their roles as family-members
and their health care are increasingly priorities for
owners [14, 15]. Clinical trials of client-owned animals
will advance both veterinary and human medicine [16].
Research colonies of cats have demonstrated their role
as biomedical models for the development of gene and
enzyme therapies [17, 18]. Indeed, gene therapy for
canine Leber’s congenital amaurosis (LCA) has restored
vision to the blind [19] and a variety of LCA clinical
trials are underway in human patients [20–23].
Congenital amaurosis (MIM: 204000) was first de-
scribed by Leber in the 1800’s [24, 25] and is now recog-
nized as a heterogeneous group of early-onset childhood
retinal dystrophies. LCA is classified as the most severe
form of retinopathy [26]. LCA has a worldwide preva-
lence of 1 in 81,000 to 1 in 33,000 newborn babies, ac-
counting for ≥ 5 % of all inherited retinopathies and
approximately 20 % of children attending schools for the
blind around the world [27–29]. Nineteen different genes
are currently associated with the various forms of LCA
[30, 31] (http://omim.org/phenotypicSeries/PS204000).
Variants at an autosomal recessive locus, LCA4 (MIM:
604393), are caused by DNA variants in AIPL1 (MIM:
604392) on human chromosome 17p13.1 [32–34].
Aryl-hydrocarbon-interacting receptor protein-like 1
(AIPL1) variants cause approximately 7 % of LCA
worldwide and may also cause dominant retinopathy
[33, 34].
The Persian cat has been proposed as an animal model
for retinal degeneration, specifically LCA [35–37]. Previ-
ous studies have localized the Persian cat progressive
retinal atrophy to a 1.3 Mb region on cat chromosome
E1, which is homologous to human chromosome 17
[35]. At the time of analysis, the publically available ref-
erence sequence, an Abyssinian cat, had over 11 Mb of
genomic sequence in unplaced scaffolds [38]. The in-
complete reference obstructed a full examination of an
LCA gene, AIPL1 within the haplotype block due to a
gap in the cat genomic sequence.
WGS is feasible for domestic cats and is a highly effi-
cient method to genetically examine several interesting
phenotypes, in one cat, that do not have overlapping or
compromising health effects. To maintain diversity in
the Persian cat colony segregating for PRA, several in-
nocuous phenotypes that are specific to pedigreed cats
were introduced by outcrossing to cats of unrelated
breeds. The bobbed tail of the Japanese bobtail cat breed
results from abnormal caudal vertebrae morphology
[39]. In addition, bobbed-tailed cats are typically lack a
vertebra from the thoracic or lumbar regions, promoting
this cat breed a model for spinal column development
and somite segmentation [40–44]. Genes involved with
somite segmentation are responsible for a severe disease
in humans and dogs, spondylocostal dysostosis [45–47].
In this study, the Persian cat PRA is defined as a new
model for LCA and the bobbed tail cat is a new model
for spinal cord development. Using WGS of a trio of cats
segregating for multiple traits, a gene within a ~1.3 Mb
targeted region of interest from a previous genome-wide
association study (GWAS) was implicated for Persian
cat PRA. Without a priori knowledge of the GWAS tar-
geted region, the LCA variant would have been identified
based on proper segregation in the trio and the present
of a stop gain variant in a known LCA gene. This feline
PRA model is now available to the vision science com-
munity for gene therapies studies, and has potential to
support both veterinary and human medicine. In
addition, a gene associated with somite segmentation
was implicated for the bobbed tail phenotype. The gen-
omic resources for the domestic cat are now making
WGS-based disease variant discovery feasible in Felis
catus, further supporting the domestic cat as a compara-
tive biomedical model for human studies.
Methods
Pedigree and clinical description
The breeding colony of Persian cats and their clinical
diagnoses of PRA and bobbed tail are previously de-
scribed [36, 39]. Cats were maintained under the Institu-
tional Animal Care and Use protocols 11977, 15117 and
16691 at the University of California – Davis (UC Davis)
and protocol 7808 at the University of Missouri. No add-
itional ethical committee approval was required or re-
quested over and above general adherence to protocols.
PRA disease status was confirmed during a complete by
ophthalmic examination performed by board-certified
veterinary ophthalmologists from the Ophthalmology
Service of the UC Davis Veterinary Medical Teaching
Hospital as described [36]. All cats were over 16 weeks
of age, therefore disease status was also confirmed by
behavioral observations as described [36]. Tail pheno-
types were confirmed by radiographs and or palpation.
Cats (N = 1740) from 40 different breeds, as well as
random bred cats, were genotyped for the variants of
interest (Additional file 1: Table S1). The majority of cats
included were Persian or Persian-derived breeds (British
shorthair, exotic, Himalayan, Scottish fold, Selkirk rex)
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[48, 49] (n = 1213), including 85 cats (59 sighted and 26
blind cats) from an established PRA colony [35, 36], 84
biased and 1044 unbiased Persian and Persian family
samples, Table 1). A subset of these cats (n = 271)
from 27 different breeds and random bred cats were
genotyped for the HES7 variant, including 36 colony
cats (24 normal tailed and 6 bobbed-tail cats). A cat
trio was selected from the larger, extended pedigree
segregating as for the maximum number of traits in-
tegrated into the colony, including two forms of PRA,
bobbed-tail, dorsally curled ears, hair length and six
coat colors (Fig. 1). The trio included a blind sire, a
non-carrier dam with a bobbed tail and a carrier off-
spring with a bobbed tail, Fig. 1).
Cat whole genome sequencing
DNA for WGS was isolated by organic extraction from
~ 3 ml of EDTA anti-coagulated whole blood that was
collected by jugular venipuncture of the trio [50]. DNA
quality and quantity was visualized using ethidium
bromide staining after agarose gel electrophoresis. Ap-
proximately 4 μg of high molecular weight DNA from
each cat was submitted to the University of Missouri
DNA Core for sequencing library preparation and Next-
Generation sequencing. Sequencing libraries were con-
structed following the manufacturer’s protocol with
reagents supplied in Illumina’s TruSeq DNA PCR-Free
sample preparation kit (#FC-121-3001) (Illumina, San
Diego, CA). Briefly, 1–2 μg of genomic DNA was
sheared using standard Covaris (Woburn, MA) methods
to prepare a 350 bp and a 550 bp library for each indi-
vidual cat of the trio. The resulting 3′ and 5′ overhangs
were converted to blunt ends by an end repair reaction
which uses 3′ to 5′ exonuclease activity and polymerase
activity. The desired size of fragment (~350 or 550 bp)
was selected by sample purification beads (AMPure XP).
A single adenosine nucleotide was added to the 3′ ends
of the blunt fragment followed by the ligation of Illu-
mina indexed paired-end adapters. The adaptor ligated
libraries were purified twice with sample purification
beads. The purified libraries then were quantified with a
Qubit assay (Life Technologies, Carlsbad, CA) and li-
brary fragment size confirmed by Fragment Analyzer
(Advanced Analytical Technologies, Inc., Ames, IA). Fi-
nally, the libraries were diluted and sequenced on a
paired-end, 100 bp read length run according to Illumi-
na’s standard sequencing protocol for the HiSeq 2000
(Illumina). The 350 bp and 550 bp libraries from all
three cats were pooled and analyzed across nine lanes of
a HiSeq 2000 (Illumina, Inc.). An average of ~30X se-
quencing coverage per cat was expected based on typical
HiSeq output per lane and the use of PCR-free libraries.
Genome alignment and variant calling
The demultiplexed 100 bp paired-end reads generated
from the two sequencing libraries for each cat were
transferred to Maverix Biomics (San Mateo, CA) for
variant detection. Raw sequencing reads were checked
for potential sequencing issues and contaminants using
FastQC [51]. Adapter sequences, primers, Ns, and reads
with quality scores below 28 were trimmed using Trim-
momatic [52]. Reads with a length < 20 bp after trim-
ming were discarded. After reassessment for quality
improvement using FastQC [53], trimmed reads were
Table 1 AIPL1 c.577C > T Genotypes in Persian and Related Breeds
Typea Population No. Wildtype (CC) Carrier (CT) Affected (TT)
Biased Pedigreeb 85 19 40 26
Persian 51 43 8 0
British Shorthair 2 2 0 0
Exotic 29 26 3 0
Himalayan 2 2 0 0
Sub-total 84 73 11 0
Unbiased Persian 707 685 22 0
British Shorthair 111 111 0 0
Exotic 103 102 1 0
Himalayan 42 42 0 0
Scottish Fold 68 67 1 0
Selkirk Rex 13 13 0 0
Sub-total 1044 1020 24 0
Total 1213 1112 75 0
aType implies if the cat samples were biased because an owner submitted a sample specifically for the PRA genotyping or unbiased because the laboratory did a
population screen of samples submitted for other genetic testing. bPedigree cats are related and not considered for allele frequency calculation. British Shorthairs,
exotic, Himalayan, Scottish fold and Selkirk rex are cat breeds derived from Persians and are members of the Persian-family of cats [48]
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mapped to the domestic cat reference genome, Felis catus
6.2 (http://www.ncbi.nlm.nih.gov/assembly/320798), using
BWA-MEM [54]. Duplicated reads were identified and re-
moved using SAMBLASTER [55]. Sequencing coverage
across the genome for each cat was measured using
DepthOfCoverage from GATK [56]. Only bases with a
Phred quality score above 28 and reads with a mapping
quality score above 20 were included in the coverage ana-
lysis. FreeBayes [57] was used to detect variants from the
read alignments. Variants with quality scores below 20 and
homopolymers were filtered from the data. The remaining
variants were annotated with dbSNP ID [58] and effect pre-
dictions using SnpEff [59] based on the Ensembl gene
model [60] of the reference genome. The reported variant
effects and severities (e.g. high or moderate) are generated
by SnpEff using variant calls, the reference genome and
transcript definitions as input. Transcript definitions were
obtained from the publicly available Ensembl website
(www.ensembl.org). Variant effect predictions were
summarized and reformatted into tab-delimited annotation
files for easy interpretation and filtering. Data tracks that
contained genotypes of the cat trio were prepared for
visualization and data comparison in the UCSC Genome
Browser [61]. Annotated variants were loaded into the vari-
ant database of the Maverix Analytic Platform that included
an interactive variant exploration tool for dynamic filtering
of variants based on selected effects, quality scores, gene
loci, and phenotypes. To verify dynamic filtering accuracy,
known phenotypic coat color variants within the trio,
reviewed in Lyons [62], were verified and visually validated,
including the loci for Agouti (ASIP), Brown (TYRP1),
Dilution (MLPH), Long fur (FGF5) and ventral white
Spotting (KIT).
Genome-wide and haplotype variants analysis
A previous GWAS localized the PRA phenotype from
position 713,552 - 2,076,816 on cat chromosome E1,
therefore the region was scanned for disease-causing
Fig. 1 First Trio of Cats WGS for Disease Variant Identification. (Left) Pedigree of cats segregating for the AIPL1 variant for Persian progressive
retinal atrophy (PRA). Circles represent females, squares represent males, open symbols indicate phenotypically normal cats; solid symbols indicate
Persian PRA-affected cats, half-filled symbols indicate obligate carrier cats. The arrows indicate the probands. AIPL1 c.577C > T genotypes are indi-
cated above each cat. Cats with an asterisk “*” are the cats used for whole genome sequencing. (Right) The trio of cats segregating for the Persian
PRA was whole genome sequenced to potentially identify the causal variant for this animal model of LCA. Cats included (top) a wildtype bobbed
tail queen (S13230), (middle) an PRA-affected normal tail sire (S14056), and (bottom) an PRA-obligate carrier female offspring (S16628) which also
displays the bobbed tail. The bobbed tail trait was introduced by female cat 11662, a pedigreed cat of the Japanese Bobtail breed
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genes and variants [35]. In addition, a list of genes causing
retinal diseases from the RetNet database (www.RetNet.org)
was obtained and variants were visually investigated within
those genes. Various studies on somite segmentation sug-
gested HES7 as a candidate for cat bobbed tail [40, 41, 43].
The gene is also located on cat chromosome E1, from pos-
ition 2,816,901 to position 2,819,548. For the tabulations in
Table 2, vcftools v0.2.12a were used to identify variants in
the GWAS haplotype or in Retnet genes [63]. Segregating
variants were defined as those in which the dam was homo-
zygous for the reference allele, the sire was homozygous for
the alternate allele and the offspring was heterozygote for
PRA and for bobbed-tail, the dam and offspring were het-
erozygote for the alternative allele and the sire was homozy-
gous for the reference allele.
AIPL1 RNA analysis and variant genotyping
Total RNA was isolated from the retina of a sighted cat
using the RNA mini kit (Invitrogen, Carlsband, CA).
Complementary cDNA was synthesized as previously de-
scribed (Gandolfi et al. [64]). The cDNA template was
subject to PCR using 10 μM of the PCR RNA forward
primer (Additional file 1: Table S2) combined with the
Invitrogen polyT primer provided in the kit. The PCR
conditions were: 94 °C x 4 min followed by 10 cycles
conducted at 94 °C for 10 s, 66 °C for 30 s, and 68 °C
for 2 min, and 20 additional cycles at 94 °C for 10 s, 62 °
C for 30 s, and 68 °C for 2 min with an additional 20 s
per cycle. The PCR products with appropriate lengths
were purified and sequenced using four internal primers
(Additional file 1: Table S2) as previously described [64].
To further correlate the suspected causative variants
with the phenotypes, archival samples representing a
subset of the colony cats and unrelated individuals
from different breeds and random bred populations
(Additional file 1: Table S1) were genotyped by direct
Sanger sequencing of PCR-generated amplicons for
AIPL1 exon 4 and the HES7 exon 1 confirmed the
variants. Primer sequences are presented in Additional
file 1: Table S2. PCR and thermocycling conditions
were conducted as previously described with anneal-
ing at 58 °C [65]. PCR products were purified and se-
quenced as previously described [66]. Genotypes were
also determined in broader cat populations (Table 1,
Additional file 1: Table S1) by the commercial genetic
typing services of the UC Davis Veterinary Genetics
Laboratory using an allele-specific oligo assay and the
University of Bristol, Langford Veterinary Services
using a pyrosequencing-based assay (Additional file 1:
Table S2). For the allele-specific assay, specificity of
each primer was increased by incorporating a
sequence mismatch and the addition of four mis-
matched bases that created a detectable product size
variant (Additional file 1: Table S2). Amplicons were
visualized on an ABI3730 DNA analyzer (Applied Bio-
systems, Foster City, CA) and analyzed using STRand
software [67]. Primers for pyrosequencing were de-
signed using PyroMark Assay Design Ver 2.0 (Qiagen,
UK) (Additional file 1: Table S2). Pyrosequencing was
undertaken after PCR amplification using GoTaq
Master Mix (Promega, UK) of genomic DNA isolated
from mouth swabs using the Nucleospin Blood kit
(Macherey-Nagel, Germany) according to the manu-
facturer’s instructions (PyroGold, Qiagen) on a Pyro-
Mark Q24 (Qiagen). Pyrosequencing PCR was
conducted using 95 °C for 2 min denaturation,
followed by 38 cycles of 95 °C for 20 s, 58 °C for
40 s. For the HES7 variant, pedigreed cats were geno-
typed using MALDI-TOF by submission to GeneSeek
(Neogene, Inc., Lincoln, NE).
Results
Availability of data and materials
Sequences were submitted to the NCBI Sequence Read
Archive (http://trace.ncbi.nlm.nih.gov/Traces/sra/sra.cgi?c
md=show&f=sra_sub_expl) under BioProject PRJNA2
88177 and included all three cats: PRA – affected, normal -
tailed sire (S14056: SRS1050848), a bobbed tail dam
(S13230: SRS1053073), and an obligate PRA carrier bobbed
tail offspring (S16628: SRS1051523). The complete AIPL1
CDS was obtained by RT-PCR of mRNA from the retina of
a sighted cat and the sequence was submitted to the NCBI
(accession #KP682504.1).
Whole genome sequence alignment, read depth and
dataset statistics
A trio of cats segregating for PRA and bobbed tail, in-
cluding a PRA – affected, normal - tailed sire (S14056:
SRS1050848), a bobbed tail dam (S13230: SRS1053073),
and an obligate PRA carrier bobbed tail offspring
(S16628: SRS1051523), was selected from the colony
Table 2 WGS Variants Identified in 30x Coverage of a Persian
Cat PRA Trio
Analysis type†
Variant* WGS trio Trio Segregation Retnet genes GWAS haplotype
SNP 14,215,442 487,324 74,852 9607
MNP 822,020 11,856 4214 644
Insertion 1,390,990 16,656 7439 636
Deletion 1,279,028 22,134 6760 663
Mixed 304,341 3314 1588 198
Total 18,011,821 541,284 94,853 11,748
*Each alternate allele identified during variant calling is considered separately
for tabulation of variant types, using the definitions at http://
snpeff.sourceforge.net/SnpEff_manual.html#eff. †The analyses are based on
feline reference genome sequence (V6.2). The GWAS identified an associated
haplotype on cat chromosome E1. For Trio Segregation, the variants
segregated with the disease phenotype as well, not just parent to offspring
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pedigree (Alhaddad et al. 2014) for WGS (Fig. 1). Over
one billion 100 bp paired - end raw reads were obtained
for each cat (1,027,975,352 in S13230, 1,100,610,902 in
S14056, and 1,246,386,562 in S16628). The sequencing
results were of relatively high quality with approximately
19 % of the reads removed after filtering out adapter se-
quences and those with low quality scores (Additional
files 2 and 3: Figures S1-S2). Because no amplification
was required to prepare the PCR-free libraries, an aver-
age of only 0.017 % duplicated reads among the six li-
braries was observed, which minimized the removal of
duplicated read alignments used for variant calling and
retained the maximum of read coverage. The mapping
rates of the libraries to the cat reference genome were
between 86.6 and 86.8 %. Average depth of coverage for
each cat in the trio was 28.3X, 30X, and 34.1X with 94.3,
93.6 and 96.1 % of the genome having above 15X -
coverage (Additional file 1: Table S3, Additional file 4:
Figure S3).
Variants analysis - genome-wide, candidate gene and as-
sociated haplotype
Compared to the reference, over 18,000,000 variants were
detected by genome-wide sequencing the cat trio. Details
for variant counts and their effects are presented in
Tables 2 and 3. The number of variants that segregated
concordantly with the PRA phenotype reduced to
approximately 541,000 when accounting for segregation –
homozygous affected sire, obligate carrier offspring and
absent in the dam and reference sequence. A list of over
220 genes associated with blindness is available in the
RetNet database (www.RetNet.org). Nearly 95,000 variants
were found within these candidate genes and nearly
12,000 variants within the previously associated haplotype
[35] (Table 3).
Considering SNP effects and their impacts (Table 3),
43 high impact variants segregated concordantly with
the PRA disease within the trio. Thirty-seven highly
damaging variants were within the RetNet candidate
genes (Table 3). The 1.3 Mb haplotype block [35], har-
bored six highly damaging variants, including the AIPL1
variant, and 45 genic moderate variants (Table 3). From
the phenotypes and specific genotypes of the cats,
known mutations for Agouti, Brown, Color, Dilution,
Long and Spotting were correctly identified by the vari-
ant calling (data not shown) [62]. The stop gain identi-
fied in AIPL1 was considered the highest priority
candidate gene mutation and was further genotyped. Ap-
proximately 101 high and moderate impact variants that
segregated properly with the bobbed-tail phenotype in
the trio were identified in 35 genes. The HES7 gene was
examined as an obvious candidate and a missense vari-
ant was identified in the coding region.
Gene analysis, experimental validation and mutation
genotyping
A stop gain was identified in AIPL1, a gene that causes
LCA, at position c.577C > T of the cat coding DNA se-
quence. The complete AIPL1 CDS was obtained by RT-
PCR of mRNA from the retina of a sighted cat and the
sequence was submitted to the NCBI (accession
#KP682504.1). The complete gene coding sequence was
obtained, including the complete sequence of exons 4, 5
and 6, which are not present in the current feline gen-
ome assembly V6.2. No polymorphisms were identified
in the obtained sequence. The cDNA amplification
Table 3 WGS variants Identified in 30x Coverage of a Persian Cat PRA Trio
Analysis typeb
Variant impacta Functional Class WGS trio Trio Segregation RetNet genes GWAS haplotype
High Stop gain 379 11 6 1
Start/Stop loss 85 5 2 -
Splice donor/acceptor 1262 9 9 1
Exon deletion 2 - - -
Frameshift 2254 18 20 4
Rare amino acid - - - -
Moderate Codon alteration 971 15 11 4
Missense 35,444 1014 544 41
Splice branch - - - -
5′ or 3′ UTR Deletion 1 - - -
Low 64,791 2072 1155 105
Modifier 16,876,221 538,148 87,816 11,018
aImpact determined by snpEff as defined by http://snpeff.sourceforge.net/SnpEff_manual.html#eff. b The analyses is based on feline reference genome sequence
(V6.2). Effect counts are higher than variant counts because they include the effects of each alternate allele on each nearby gene isoform. GWAS haplotype are
the variants identified within the haplotype region. For Trio Segregation, the variants segregated with the disease phenotype as well, not just parent to offspring
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generated a 987 bp long CDS and in silico sequence
translation of feline wild-type AIPL1 generated from
RNA (GenBank: KP682504) predicted a length of 329
amino acids, matching Mus musculus predicted AIPL1
(Additional file 5: Figure S4). The mutated AIPL1 tran-
script encoded a predicted p.Arg193* protein truncation,
preventing translation of approximately 40 % of the pro-
tein when compared to the wild-type sequence. When
compared to human, the feline and mouse predicted
AIPL1 amino acid sequences were 56 amino acids
shorter, confirming that the proline-rich protein C-
terminal is absent in these species. Feline DNA identity
with human coding sequence (GenBank: NM_014336.4)
was 76 and 80 % when compared to mouse (GenBank:
XM_053245.2) while feline protein identity was 77 %
when compared with both species. Feline protein se-
quence alignment suggested the presence of highly con-
served domains when compared to the human segment:
an N-terminal FK506 binding protein (FKBP-like do-
main) and three C-terminal tetratricopeptide repeats
(TPR1, TPR2, TPR3). Homology between the feline and
human FKBP, TPR1, TPR2 and TPR3 domains was 91,
94, 97 and 97 % respectively. The truncated cat protein
lacked part of the TPR1 domain and the entire TPR2
and TPR3 domains.
A c.5A >G causing a p.V2A amino acid substitution
was the only coding region alteration identified in HES7,
which also segregated properly in the trio and was not
present in the reference sequence. Sequence homology of
cat (XM_003996191.2) and human (NM_001165967.1) is
89.9 % and protein identity is 91.4 %. The p.V2A amino
acid change is prior to the defined basic helix-loop-helix
and orange domains. The cat protein is also proline rich
from p.128 to the C – terminus.
Cats (N = 1740, distributed as follows: unbiased individ-
uals = 1558, Persian colony pedigree = 85, biased individ-
uals = 97) from 40 different breeds, including 36 random
bred cats and 61 cats with unknown origins were geno-
typed for the AIPL1 variant (Table 1, Additional file 1:
Table S1). A sub-set of cats (n = 271) was genotyped for
the c.5A >G HES7 variant. Twenty-six of 85 cats from the
multi-generational pedigree and verified by ophthalmic
examination to be phenotypically affected were confirmed
as homozygous for the c.577C > T variant, including all
three pedigree founders (Fig. 1). For 59 cats verified by
ophthalmic assessment to be unaffected, 19 were homozy-
gous wild-type and 40 heterozygous (Table 1, Additional
file 1: Table S1). A majority of sighted offspring in the
pedigree were expected to be heterozygous because most
of the breedings were performed as test crosses of an obli-
gate carrier to an affected mate (Fig. 1). Cats from breeds
related to the Persian breed and at risk for the AIPL1 vari-
ant included Persian, Scottish fold, Selkirk rex, British
shorthair, burmilla, exotic shorthair, and Himalayan cats.
No cats from a breed genetically unrelated to Persian cats
had the AIPL1 variant. No cats except those in the colony
with bobbed tails (n = 6) and cats of the Japanese bobtail
breed (n = 14) had the HES7 variant. All colony cats were
heterozygous for the HES7 variant, while pedigreed Japa-
nese bobtails were homozygotes. To estimate the variant
frequency within the Persian and Persian family of breeds,
1044 cats were genotyped by two commercial service la-
boratories (Table 1, Additional file 1: Table S1). These
samples were originally submitted for other genetic testing
services. In this unbiased sampling, 24 cats were heterozy-
gous, including 22 Persians, one Scottish fold and one
exotic, suggesting an allele frequency of 1.15 %. Addition-
ally, 84 cats were specifically submitted for PRA genotyp-
ing by cat owners, eleven were heterozygous and none
were homozygous for the variant, suggesting a 6.55 % al-
lele frequency. Because these samples were submitted by
owners for PRA genotyping, the sampling is biased and
the allele frequency is likely high, especially because some
cats may be siblings in a litter.
Discussion
Besides traditional rodent models, WGS has been used in
cattle [68] and dogs [69–71] to identify disease mutations,
however, the datasets have included hundreds of individ-
uals for comparison. More recently, a WGS of a single cat
was used to confirm a previously identified phenotypic
variant for White [72] and a single cat compared to a vari-
ant database including 18 cats identified a feline model for
Congenital Myasthenic Syndrome [47, 73]. However, the
cat variant database needs to be improved for continued
success, particularly for genetic studies in non-pedigreed,
random bred cats [38, 74, 75]. WGS of more than one in-
dividual with an inherited disease that is identical by des-
cent can overcome the lack of a deep variant database.
The present study represents the first comprehensive
WGS effort to identify causal mutations in the domestic
cat, allowing assessment of the efficiency of the WGS
and variant calling process using the current cat refer-
ence assembly. In addition, other traits also segregating
in this cat trio, including the bobbed tail of the Japanese
bobtail breed, dorsally curled ears of the American curl,
hair length, and at least six color variants were available
for analysis. A targeted sequencing depth 30X genomic
coverage was selected because of the number of variants
that can be identified and the fraction of the genome
that is callable plateaus above this depth of coverage
[76]. Deep WGS of the trio of cats, including one non -
PRA affected bobbed tail parent, one PRA - affected non
– bobbed tail parent, and one obligate PRA carrier,
bobbed tail offspring was conducted to fill sequence gaps
in the targeted GWAS region for PRA in Persian cats
and to support accurate variant calling. Variation was
high in this trio because the family included outcrosses
Lyons et al. BMC Genomics  (2016) 17:265 Page 7 of 11
to several different cat breeds, including Persian, Oriental
shorthair, American curl, Somali, and Bengal. Of the ap-
proximately 18 million variants identified, only 541,284
(3.0 %) had genotypes that segregated with the Persian cat
PRA phenotype, 94,853 were in genes associated with vi-
sion loss (RetNet), and 11,748 that were within the GWAS
haplotype region. By examining high-impact variants, stop
gains were reduced from 379 overall to 11 segregating
within the trio and with the phenotypes. Six stop gains
were in RetNet genes and only one was in the haplotype
region within an obvious LCA candidate gene, AIPL1.
Thus, without the GWAS and a list of candidate genes,
eleven stop gains would likely have been prioritized and
examined over the other 32 high-impact variants segregat-
ing in the trio. Without the trio and other cat genomes for
comparison, many thousands of variants could have been
considered of high impact and would have required
prioritization.
The DNA variant identified in the present study is a
few bases upstream of a gap in the reference sequence.
RNA sequencing provided the complete coding DNA se-
quence of AIPL1. AIPL1 mutations affecting vision are
grouped into three classes: the first class of missense
mutations is located in the N-terminus, the second class
of missense and stop mutations is located in the TPR
motifs, and the third class of mutations includes small
in-frame deletions located in the C-terminus. The first
and second classes of mutations are associated with
autosomal recessive LCA, while mutations in the third
class appear to be associated with autosomal dominant
cone-rod dystrophy and juvenile RP [34].
The abnormal vertebral presentation in the Japanese
bobtail cats was an unexpected finding [39] that could
be clearly associated with genes involved with somite
segmentation [40–44]. The cat trio was purposely se-
lected to segregate for a variety of traits to assist inter-
pretation of the efficiency of the cat reference assembly
and WGS efforts. The identified c.5A > G missense
variant predicts a p.V2A alteration in HES7 that appears
to act dominantly to disrupt feline vertebral column
development, leading to absence of either one thoracic
or lumbar vertebrae and misplacement of ribs [39].
Homozygous cats have no additional abnormalities, but
do have more predictable “show quality” tails. In
humans, HES7 missense changes p.R25W, p.I58V and
p.D186Y cause autosomal recessive spondylocostal
dysostosis (SCDO4, OMIM:613686) [45, 46].
Segregation of the AIPL1 and HES7 variants was con-
firmed in an extended pedigree of Persian cats with PRA
and the introduced bobbed-tail trait. The PRA founders
of the pedigree were from three geographically wide-
spread locations in the USA, and from distinct lines of
Persian cats. These cats were ascertained as adults in
1999 for the breeding colony, thus this form of PRA has
been in the Persian population for at least 15 years. The
Persian breed is the largest by population in the Cat Fan-
ciers’ Association with over 60 % of registered cats being
represented by Persians and related breeds, such as
exotic shorthairs, Himalayans, Selkirk rex, Scottish fold,
and British shorthairs [77]. With an allele frequency of
1.15 %, and considering an average lifespan of 12 years
and a population size of at least 500,000 pedigree cats
from Persian-family breeds, approximately 66 may have
vision loss due to the AIPL1 variant with approximately
11,367 carriers in the population. The HES7 variant was
private to the Japanese bobtail breed and not identified
in any normal tailed breeds, however, additional bobbed
tailed breeds should be examined.
The cat eye has many structural and functional simi-
larities with the human eye, including a dual retina with
rod photoreceptors that greatly outnumber cones [78].
Due to similarities between the feline and human eye,
the cat has been used extensively for research involving
retinal structure and visual function. Two inherited fe-
line retinal degenerations with known causal variants are
defined in Abyssinian cats. The centrosomal protein 290
(CEP290) cat model [79] harbors variants also seen in
approximately 30 % of humans with LCA10 [80] and the
cone rod homeobox gene (CRX) is a LCA7 model [81].
The present study describes a third model, characterized
by a rapidly progressive retinal dystrophy due likely to
AIPL1 deficiency. This new model should advance un-
derstanding of LCA4 pathology.
Conclusions
The three cats reported here represent the first individ-
uals to be sequenced as part of the 99 Lives Cat Genome
Sequencing Initiative (www.felinegenetics.missouri.edu/
99lives). Identified is a stop mutation in AIPL1 of the
Persian cat at position c.577C > T of the CDS producing
a p.Arg193*, as predicted by the human sequence,
knocking out approximately 40 % of the normal protein.
Additionally, a HES7 c.5A > G variant is associated with
the bobbed tail of the Japanese bobtail breed. Cats have
a longer life span than mice, affording researchers the
opportunity for repeated and extended trials of gene and
stem cell administration. Due to their increased longev-
ity and larger globe relative to mice, and physiology
more similar to humans, cats represent an efficient and
effective model for LCA gene - and stem cell therapies.
Additional files
Additional file 1: Table S1. AIPL1 c.577C > T and HES7 c.5A > G
Genotypes in Domestic Cats. Table S2. Primer Sequences for the Analysis
of AIPL1 in Domestic Cats. Table S3. Genome Coverage of Persian Cat
PRA Trio. (DOCX 32 kb)
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Additional file 2: Figure S1. Representative Base Quality Scores of
Untrimmed Sequencing Reads for the Persian cat trio. Base-specific quality
scores were aggregated and plotted using FastQC (already cited, 27 and 29).
Phred-scaled quality scores (y axis) are plotted against base position within
the read (x axis). Box spans second and third quartiles; whiskers indicate 10th
and 90th percentiles. Median and mean are plotted as red and blue lines
respectively. The data aggregated here represents end X of untrimmed reads
from a single library data in a single lane. (PNG 15 kb)
Additional file 3: Figure S2. Sequencing Reads in the Persian Cat Trio.
Quality assessment (removing low quality bases, trimming adapters and
subsequently excluding reads under 20 bases) reduced the number of
reads for each library and lane. Fewer reads were generated from 550 base
pair libraries (those containing the text “Lib550”). The unique read counts
displayed here were calculated by FastQC; duplicates reported in the text
were calculated from marked duplicates among mapped reads. a) Cat
13230 non-carrier queen, b) Cat 14056 affected sire, and c) Cat 16628 carrier
offspring. (ZIP 229 kb)
Additional file 4: Figure S3. Bases within a Given Depth of Sequence for
WGS Persian Cats. The red and green lines represent the average coverage
of the parents (S13230 and S14056) and the blue line represents the
average coverage of the offspring (S16628). (PNG 253 kb)
Additional file 5: Figure S4. AIPL1 Protein Sequence Alignments.
Presented are sequences for Homo sapiens, Mus musculus, Felis silvestris
catus and Felis silvestris catus with the identified mutation. In green, blue,
purple and grey sequences of different domains inferred using the Homo
sapiens domain protein annotation (www.uniprot.org). In yellow, residues
that differ between the Homo sapiens and Mus musculus when compared
to the feline protein sequence. The AIPL1 feline mutated sequence lacks
partial TRP1 and TRP2 and TRP3. (DOCX 151 kb)
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